Related Experiment Video
Updated: May 29, 2026
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
CD40/CD40 ligand interactions in immune responses and pulmonary immunity
Tsutomu Kawabe1, Miyoko Matsushima, Naozumi Hashimoto
1Department of Medical Technology, Nagoya University School of Health Sciences, Nagoya, Japan. kawabe@met.nagoya-u.ac.jp
Nagoya Journal of Medical Science
|September 21, 2011
Summary
The CD40 ligand/CD40 pathway is crucial for immune responses. Dysregulation of this pathway contributes to various inflammatory diseases, highlighting its role in disease pathophysiology.
Area of Science:
- Immunology
- Molecular Biology
- Pathophysiology
Background:
- The CD40 ligand/CD40 pathway is essential for immune regulation and homeostasis.
- CD40 is expressed on antigen-presenting cells, non-immune cells, and tumors.
- CD40 ligand engagement regulates adaptive immunity, cellular, and humoral processes.
Purpose of the Study:
- To discuss the CD40 ligand/CD40 interaction's role in inflammatory disease.
- To explore the involvement in autoimmune diseases, atherothrombosis, cancer, and respiratory diseases.
Main Methods:
- Review of recent research findings.
- Discussion of the CD40 ligand/CD40 interaction in disease pathophysiology.
Main Results:
- The CD40 ligand/CD40 pathway is implicated in various inflammatory conditions.
- Deregulated CD40 ligand levels contribute to disease development.
Conclusions:
- The CD40 ligand/CD40 interaction is a key factor in the pathophysiology of multiple inflammatory diseases.
- Understanding this pathway is vital for therapeutic strategies in autoimmune diseases, atherothrombosis, cancer, and respiratory diseases.
